Core Viewpoint - The announcement details the share reduction by major shareholders of Zhejiang Gongdong Medical Instrument Co., Ltd., including the results of the reduction and changes in equity ownership [1][10]. Group 1: Shareholder and Ownership Information - The controlling shareholder, Shi Huiyong, held 110,836,040 shares, representing 50.27% of the total share capital before the reduction. Taizhou Jinch Investment Management Partnership held 14,258,009 shares, accounting for 6.47% [2]. - After the reduction, Shi Huiyong holds 106,433,640 shares (48.27%), while Jinch Investment holds 12,053,169 shares (5.47%) [3]. Group 2: Reduction Plan Implementation Results - The reduction plan was announced on September 5, 2025, allowing Shi Huiyong to reduce up to 4,409,858 shares and Jinch Investment to reduce up to 2,204,929 shares within the specified period from September 26 to December 24, 2025 [3][8]. - By December 16, 2025, Shi Huiyong had reduced 4,402,400 shares, and Jinch Investment had reduced 2,204,840 shares, completing the reduction plan [3][11]. Group 3: Equity Change Details - The equity change occurred between October 31 and December 16, 2025, with Shi Huiyong and Jinch Investment's combined shareholding decreasing from 141,017,809 shares (63.96%) to 134,950,809 shares (61.21%) [9]. - The reduction did not trigger a mandatory tender offer and will not significantly impact the company's governance structure or ongoing operations [10].
浙江拱东医疗器械股份有限公司股东减持股份结果暨权益变动触及1%刻度公告